Recent News

• 03.20.2026 - Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer
• 03.09.2026 - Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
• 03.04.2026 - Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Recent Filings

• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 3 Initial statement of beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities